Page Tools:

Dx/Rx: Liver Cancer

Author(s): Ghassan K. Abou-Alfa, MD, Gastrointestinal Service, Memorial Sloan-Kettering Cancer Center, Weill-Medical College, Cornell University, New York, New York
Celina Ang, MD, Fellow, Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York
Details:
  • ISBN-13: 9781449646868
  • Paperback    154 pages      © 2013
Price: $62.95 US List
Add to Cart

Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver.

Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Chapter  1  Epidemiology
Chapter  2  Clinical Features
Chapter  3  Diagnostic Workup
Chapter  4  Staging and Prognosis
Chapter  5  Histopathology
Chapter  6  Genetics and Molecular Biology
Chapter  7  Management
Chapter  8  Surveillance, Screening, and Prevention
Chapter  9  Future Trends and Controversies

Ghassan K. Abou-Alfa, MD-Gastrointestinal Service, Memorial Sloan-Kettering Cancer Center, Weill-Medical College, Cornell University, New York, New York

Ghassan K. Abou-Alfa, MD, is a member of the Gastrointestinal Oncology Service at Memorial Sloan-Kettering Cancer Center in New York, where he specializes in the treatment of primary liver cancer. He received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine, before joining the faculty of Memorial Sloan-Kettering. His research is dedicated to improving the effectiveness of cancer therapy by incorporating small biological molecules that target cancer therapy into the treatment regimen for chemotherapy-resistant liver cancer. Dr. Abou-Alfa is a strong advocate for raising awareness about liver cancer and has lectured on the subject at universities worldwide.

Additional Titles by this Author

Celina Ang, MD-Fellow, Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York

  • This is an excellent resource for physicians in training as well as practicing oncologists caring for patients with hepatocellular carcinoma. The authors of DxRx Liver Cancer have compiled and distilled the latest, most relevant data on all aspects relating to the study and management of this complex disease into a comprehensive, portable and practical reference.

     
    Alan Venook
    Professor of Clinical Medicine
    Chief, Gastrointestinal Oncology
    University of California